The Greenshoots Digest - Issue #11
?
A summary of?the latest discussion, analysis and commentary on the issues relevant to those who own, invent or manage intellectual property (IP), from the IP specialists of Appleyard Lees.
?
Malaria: new vaccines hailed as a breakthrough in the fight against the disease
Discover how integrating recently developed malaria vaccines, RTS,S and R21, with existing control measures in Africa sets out a promising path towards the near eradication of malaria.
In this article, Senior Attorney, Sarah Gibbs , explores how the launch of these malaria vaccines marks a critical milestone in combating the disease.??
?Episode 45?
Commercialising innovation: five golden rules for licensors and licensees when licensing IP
In this episode, Amritjot Jethwa, Head of Commercial IP Contracts, and Chris Hoole, Partner, provide a quick-fire summary of 5 important factors to consider as a licensor, and as a licensee, when licensing technology - creating the building blocks for the successful commercialisation of IP.
Sanofi and Regeneron vs Amgen – UPC’s first revocation decision
?The first revocation decision from the Unified Patent Court (UPC) has seen a win for Sanofi and Regeneron, in a dispute with Amgen over cholesterol lowering drugs. In this article, Associate, David Jasiewicz and, Senior Associate, Sarah Gibbs, discuss the recent and eagerly anticipated first revocation decision from the UPC.?
?